Univasc Articles
US FDA approves Teva's generic Uniretic
19 March 2007
Schwarz Pharma's revenue up 4.6% in 2005
27 February 2006
Schwartz Pharma boosted by US sales
9 May 2005
Schwarz Pharma wins Univasc case
17 January 2005
Teva's generic Univasc cleared in USA
19 May 2003
Schwarz Pharma looks to have turned corner
12 November 2001
Schwarz Pharma net income up 65% as operating loss narrows
21 February 2001
NCEs In 1995: A Good Range Of Novel Drugs
29 January 1996
Moexipril Takes On Other ACEIs On Price
29 January 1996
US FDA Approving Fewer NMEs, But Faster, In 1995
11 September 1995
Schwarz' Univasc Cheapest ACE Inhibitor?
17 July 1995
Schwartz Pharma; Univasc
22 May 1995
MOEX "APPROVABLE"
8 August 1994
SCHWARTZ RECEIVES APPROVABLE LETTER
30 May 1994
Showing 1-16 of 16 articles
- 1
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
